Cargando…
P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747376/ http://dx.doi.org/10.1016/j.jval.2022.09.013 |
| _version_ | 1784849582547533824 |
|---|---|
| author | Mar, J. Ibarrondo, O. Larrañaga, I. Aguiar, M. Stollenverk, N. Bidaurrazaga, J. Estadillo, C. Blasco, R. |
| author_facet | Mar, J. Ibarrondo, O. Larrañaga, I. Aguiar, M. Stollenverk, N. Bidaurrazaga, J. Estadillo, C. Blasco, R. |
| author_sort | Mar, J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9747376 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97473762022-12-14 P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021 Mar, J. Ibarrondo, O. Larrañaga, I. Aguiar, M. Stollenverk, N. Bidaurrazaga, J. Estadillo, C. Blasco, R. Value Health COVIDnomics Published by Elsevier Inc. 2022-12 2022-12-14 /pmc/articles/PMC9747376/ http://dx.doi.org/10.1016/j.jval.2022.09.013 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | COVIDnomics Mar, J. Ibarrondo, O. Larrañaga, I. Aguiar, M. Stollenverk, N. Bidaurrazaga, J. Estadillo, C. Blasco, R. P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021 |
| title | P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021 |
| title_full | P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021 |
| title_fullStr | P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021 |
| title_full_unstemmed | P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021 |
| title_short | P1 Cost-Utility Analysis of COVID-19 Vaccines in the Basque Country in the First Semester of 2021 |
| title_sort | p1 cost-utility analysis of covid-19 vaccines in the basque country in the first semester of 2021 |
| topic | COVIDnomics |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747376/ http://dx.doi.org/10.1016/j.jval.2022.09.013 |
| work_keys_str_mv | AT marj p1costutilityanalysisofcovid19vaccinesinthebasquecountryinthefirstsemesterof2021 AT ibarrondoo p1costutilityanalysisofcovid19vaccinesinthebasquecountryinthefirstsemesterof2021 AT larranagai p1costutilityanalysisofcovid19vaccinesinthebasquecountryinthefirstsemesterof2021 AT aguiarm p1costutilityanalysisofcovid19vaccinesinthebasquecountryinthefirstsemesterof2021 AT stollenverkn p1costutilityanalysisofcovid19vaccinesinthebasquecountryinthefirstsemesterof2021 AT bidaurrazagaj p1costutilityanalysisofcovid19vaccinesinthebasquecountryinthefirstsemesterof2021 AT estadilloc p1costutilityanalysisofcovid19vaccinesinthebasquecountryinthefirstsemesterof2021 AT blascor p1costutilityanalysisofcovid19vaccinesinthebasquecountryinthefirstsemesterof2021 |